Skip to main content
Medtide Inc. logo

Medtide Inc. — Investor Relations & Filings

Ticker · 3880 ISIN · CNE100006S86 LEI · 254900EYF65J0WV87333 HKEX Manufacturing
Open in API
Filings indexed 39 across all filing types
Latest filing 2025-11-05 Regulatory Filings
Country CN China
Listing HKEX 3880

About Medtide Inc.

https://medtideinc.com

Medtide Inc. is a specialized, peptide-focused Contract Research, Development, and Manufacturing Organization (CRDMO). It offers full-cycle services, including peptide New Chemical Entity (NCE) discovery synthesis (CRO services), preclinical research, clinical development, and commercial production (CDMO services). The company's primary focus is providing Active Pharmaceutical Ingredients (APIs) to pharmaceutical clients, leveraging expertise across the entire peptide drug development lifecycle.

Recent filings

Filing Released Lang Actions
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 October 2025
Regulatory Filings Classification · 90% confidence The document is a standard FF301 monthly return filed with HKEX under Chapter 19B of the Listing Rules, detailing movements in authorised/registered share capital, issued shares, treasury shares, and confirmations. It is not an annual report, earnings release, call transcript, or specific capital raising notice, nor does it announce a dividends, board changes or an M&A. It is a periodic regulatory submission that does not fit other precise categories, so it falls under the general “Regulatory Filings” (RNS) fallback category.
2025-11-05 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 September 2025
Regulatory Filings Classification · 92% confidence The document is a Monthly Return under Chapter 19B of the HKEX Listing Rules detailing movements in authorised, issued, and treasury share capital for a specified month. It is a routine regulatory listing submission rather than an annual or interim financial report, earnings release, proxy statement, or capital-raising announcement. There is no indication of a dividend, management change, M&A, or share issue event notice. This type of monthly listing rule compliance document falls under the general Regulatory Filings category.
2025-10-06 English
CHANGE OF JOINT COMPANY SECRETARY, AUTHORISED REPRESENTATIVE AND PROCESS AGENT&#x3b; AND WAIVER FROM STRICT COMPLIANCE WITH RULES 3.28 AND 8.17 OF THE LISTING RULES
Board/Management Information Classification · 88% confidence The document is an announcement on the Stock Exchange of Hong Kong regarding the resignation of the joint company secretary and authorised representative, the appointment of a new joint company secretary and authorised representative, and related waivers under listing rules. It is focused on changes in company secretary and senior management roles rather than presenting financial results or full report content. This fits the Board/Management Information category (MANG).
2025-09-26 English
2025 INTERIM REPORT
Interim / Quarterly Report Classification · 100% confidence The document is titled '2025 INTERIM REPORT' for Medtide Inc. It contains comprehensive financial statements (Profit or Loss, Comprehensive Income, Financial Position, Changes in Equity, Cash Flows), notes to the financial information, and a detailed Management Discussion and Analysis (MDA) section covering the six-month period ended June 30, 2025. It is a full interim financial report, not an announcement or a summary. H1 2025
2025-09-25 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 August 2025
Regulatory Filings Classification · 90% confidence The document is a monthly return (Form FF301) submitted to the Hong Kong Stock Exchange under Chapter 19B of the Listing Rules, detailing movements in authorized/issued share capital and share movements. It does not announce a specific new financing event, proxy matter, dividend, management change, or earnings data but is a recurring regulatory return. It does not fit more specific categories and serves as a general regulatory filing, so the appropriate classification is RNS (Regulatory Filings).
2025-09-03 English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2025
Interim / Quarterly Report Classification · 100% confidence The document is an 'Interim Results Announcement' for Medtide Inc. for the six months ended June 30, 2025. It contains detailed financial highlights, management discussion and analysis (MDA), operating data, and business reviews. While it is titled an 'announcement', it provides the actual financial statements and substantive analysis required for an interim report, distinguishing it from a mere publication notice. Therefore, it is classified as an Interim/Quarterly Report. H2 2025
2025-08-29 English

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.